Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Proteins » Cystatins: Protease Inhibitors, Biomarkers and Immunomodulators Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Cystatin C, Atherosclerosis and Lipid-Lowering Therapy by Statins pp. 187-204
Tell A Friend
Tell someone you know about this product.
Cystatin C, Atherosclerosis and Lipid-Lowering Therapy by Statins pp. 187-204 $0.00
Authors:  (T.A. Korolenko, M.S. Cherkanova, E.A. Gashenko, T.P. Johnston, I. Yu. Bravve, Institute of Physiology, Siberian Branch of the Russian Academy of Medical Sciences, Novosibirsk, Russia, and others)
The search for new serum markers of aging, atherosclerosis, and predictors of cardiovascular emergencies is important in contemporary society. Recently, new nonlipid markers of atherosclerosis and predictors of cardiovascular events were introduced. These markers are related to inflammation and macrophage stimulation, such as cystatin C, matrix metalloproteases (MMPs), and chitotriosidase. Increased serum cystatin C concentration, an alternative measure of renal function, is now suggested as a strong predictor of cardiovascular events. We compared new non-lipid atherosclerosis indexes with common inflammatory (hs-CRP) and lipid markers in elderly persons and patients with atherosclerosis and ischemic heart disease (IHD) who have undergone coronary bypass surgery. Cystatins are known to be very potent endogenous inhibitors of cysteine proteases of the papain superfamily. They form equimolar, tight, and reversible complexes with human cysteine proteases (cathepsins B, H, K, L and S), and express different cellular functions as proteins (cell proliferation, degradation of extracellular matrix, etc.). In
humans, cystatin C, localized predominantly in the extracellular space, was used for early detection of impaired kidney function, as well as a marker in several inflammatory and tumor diseases. The question of whether cystatin C is an atherogenic or protective
protein, as well as its possible role as a marker or predictor in IHD is still not clear. 

Available Options:

  Open Access item.
  Click below PDF icon for free download.


This is an Open Access item. Click above PDF icon for free download.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2022

Cystatin C, Atherosclerosis and Lipid-Lowering Therapy by Statins pp. 187-204